Molecules/RITUXIMAB

RITUXIMAB

Molecular Identity

AntibodyApprovedFirst approved 1997

Mechanism of action: B-lymphocyte antigen CD20 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

ABP-798ABP798BI 695500BI-695500BI695500BLITZIMACT-P10GP-2013GP2013HS-006HS006HS-006 (RITUXIMAB BIOSIMILAR)IDEC-102IDEC102IDEC-C 2B8

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to RITUXIMAB

Loading drug network...